27
total announcements
LALPATHLAB.NS · 15 min delayed
Dr. Lal Path Labs Ltd.
Dr. Lal Path Labs Ltd. has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming compliance under Regulation 74(5) for the quarter ended June 30, 2026.
Dr. Lal Path Labs Ltd.
Dr. Lal Path Labs Ltd. has informed the Exchange about the dispatch of Notice of 32nd Annual General Meeting and Annual Report for FY 2025-26 to the Members of the Company.
Dr. Lal Path Labs Ltd.
Dr. Lal Path Labs Ltd. has dispatched a letter to its members providing a web-link to access the Annual Report for FY 2025-26, as per Regulation 36(1)(b) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Dr. Lal Path Labs Ltd.
Dr. Lal Path Labs Ltd. has submitted its Business Responsibility and Sustainability Report for the Financial Year 2025-26, as required by SEBI regulations.
Dr. Lal Path Labs Ltd.
Dr. Lal Path Labs Ltd. has informed the Exchange regarding Notice of Annual General Meeting to be held on July 25, 2026.
Dr. Lal Path Labs Ltd.
Dr. Lal Path Labs Ltd. has informed the Exchange about a copy of newspaper publication regarding the 32nd Annual General Meeting of the Company to be held on July 25, 2026 through Video Conferencing/Other Audio Visual Means.
Dr. Lal Path Labs Ltd.
Dr. Lal Path Labs Ltd. has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, ahead of the Board meeting to consider un-audited financial results for the quarter ending June 30, 2026.